PEP-Therapy

Healthcare 📍 France 👥 1001-5000 employees 💰 $1.4M raised 📅 Founded 2014

PEP-Therapy SAS is a biotech company developing targeted therapies for the treatment of severe diseases, with an initial focus on cancer. PEP-Therapy develops Cell Penetrating and Interfering Peptides (CP&IP) for the intracellular delivery of targeted therapies. These active compounds penetrate cells and block relevan

🌐 Website in LinkedIn ← All Companies

📊 Company Overview

Sector

Healthcare

Country

France

Employees

1001-5000

Total Raised · Venture

$1.4M

Founded

2014

Cloud

Unknown

Email

Microsoft 365

☁️ Cloud Infrastructure

🔒 Subscribers only Cloud Provider

Workspace	Microsoft 365
CDN	🔒 Subscribers only

Detected via DNS records and HTTP response headers as of 2026-06-13.

💰 Estimated Cloud Spend

$11M – $27M / year across cloud providers

🛠 Tech Stack & Marketing

Ad Platforms	🔒 Subscribers only
Analytics & CRM	Google Analytics
CMS / Platform	WordPress
Frontend Stack	🔒 Subscribers only

Detected from PEP-Therapy's public homepage as of 2026-06-13.

🔍 Compare with Similar Companies

Same sector (Healthcare), similar size

Peloton Interactive

1001-5000 ☁️ Vercel

1001-5000 ☁️ Unknown

1001-5000 ☁️ AWS

Data detected 2026-06-13 · Methodology · Suggest a correction